Back to Journals » Journal of Healthcare Leadership » Volume 13

A Methodology for Mapping the Patient Journey for Noncommunicable Diseases in Low- and Middle-Income Countries

Authors Bharatan T, Devi R, Huang PH, Javed A, Jeffers B, Lansberg P, Sidhu K, Subramaniam K

Received 3 November 2020

Accepted for publication 10 January 2021

Published 29 January 2021 Volume 2021:13 Pages 35—46


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Russell Taichman

Video abstract of "A methodology for mapping the patient journey for NCDs in LMICs" [ID 288966].

Views: 41

Tanaya Bharatan,1 Ratna Devi,2,3 Pai-Hui Huang,4 Afzal Javed,5 Barrett Jeffers,6 Peter Lansberg,7 Kaveri Sidhu,1 Kannan Subramaniam8

1Research Development & Medical, Upjohn Division, Pfizer Ltd, Mumbai, India; 2Executive Office, Daksham A Health and Education, Gurgaon, India; 3International Alliance of Patient Organizations, London, UK; 4Medical Affairs, Viatris, Taipei, Taiwan; 5Warwick Medical School, University of Warwick, Warwick, UK; 6Medical Affairs, Viatris Inc, New York, NY, USA; 7Department of Pediatrics, University Medical Center, Groningen, the Netherlands; 8Medical Affairs, Viatris | Mylan New Zealand Ltd, Auckland, New Zealand

Correspondence: Kannan Subramaniam
Viatris | Mylan New Zealand Ltd, PO Box 11183, Ellerslie, Auckland 1542, New Zealand
Tel +64 21 592 064
Fax +61 2 8080 8181

Abstract: Noncommunicable diseases (NCDs) are responsible for 71% of all worldwide mortality each year, and have an exceptionally large impact in low- and middle-income countries (LMICs). However, there is often a lack of local data from these countries to inform practice and policy improvements. Generating locally contextualized evidence base for NCDs that can help identify gaps, aid decision-making and improve patient care in LMICs needs an innovative approach. The approach used in Mapping the Patient Journey Towards Actionable Beyond the Pill Solutions (MAPS) is designed to quantitatively map different stages of the patient journey in four critical NCDs, ie, hypertension, dyslipidemia, depression, and pain (chronic and neuropathic) across selected LMICs in Africa, the Middle East, South East Asia, and Latin America. The key touchpoints along the patient journey include awareness, screening, diagnosis, treatment, adherence, and control or remission. MAPS employs an evidence mapping methodology that follows a three-step semi-systematic review: 1) systematic peer-reviewed database search; 2) unstructured searches of local or real-world data; and 3) expert opinion. Evidence generation and visualization is based on locally validated and deduplicated data published over the last 10 years. This approach will be the first to provide quantitative mapping of the different stages of the patient journey for selected NCDs in LMICs. By focusing on local, patient-centric data, the goal of the MAPS initiative is to address and prioritize local research and knowledge gaps, then contribute to evidence-based, high-quality, and affordable advances in the management of NCDs in LMICs. This will ultimately improve patient outcomes and contribute towards the achievement of global NCD targets.

Keywords: noncommunicable diseases, low- and middle-income countries, decision-making, patient journey, evidence mapping

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]